Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial.

Vivian Kliim-HansenLærke Smidt GasbjergAnne-Marie EllegaardHans Johan Niklas LorentssonMads Bank LynggaardChristoffer Andersen HagemannChristian LegartDavid Siersbæk MathiesenPradeesh SivapalanJens-Ulrik Stæhr JensenTina VilsbøllMikkel Bring ChristensenFilip K Krag Knop

Published in: BMJ open (2022)

2020-001544-26; NCT04351581.

Keyphrases

study protocol
open label
randomized controlled trial
phase iii
double blind
phase ii
coronavirus disease
clinical trial
sars cov
placebo controlled